Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Cingulate Inc.
Cingulate Announces Presentation of Full Trial Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHD at Psych Congress 2023
September 05, 2023
From
Cingulate Inc.
Via
GlobeNewswire
Tickers
CING
CINGW
Cingulate Inc. Reports Second Quarter 2023 Financial Results and Provides Clinical and Business Update
August 14, 2023
From
Cingulate Inc.
Via
GlobeNewswire
Tickers
CING
CINGW
Cingulate Announces Positive Top-Line Results from Phase 3 Adult Efficacy and Safety Trial of CTx-1301 (dexmethylphenidate) for ADHD
July 11, 2023
From
Cingulate Inc.
Via
GlobeNewswire
Tickers
CING
CINGW
Cingulate Successfully Manufactures Clinical Supply – Initiation of Pediatric Phase 3 Studies to Commence in July and August
June 29, 2023
From
Cingulate Inc.
Via
GlobeNewswire
Tickers
CING
CINGW
Cingulate Completes Phase 3 Adult Trial of CTx-1301 (dexmethylphenidate) for ADHD
June 08, 2023
From
Cingulate Inc.
Via
GlobeNewswire
Tickers
CING
CINGW
Cingulate to Present at 13th Annual LD Micro Invitational
May 25, 2023
From
Cingulate Inc.
Via
GlobeNewswire
Tickers
CING
CINGW
Cingulate, Indegene to Participate in Benzinga All Live Access Event
May 12, 2023
From
Cingulate Inc.
Via
GlobeNewswire
Tickers
CING
CINGW
Cingulate Inc. Reports First Quarter 2023 Financial Results and Provides Clinical and Business Update
May 10, 2023
From
Cingulate Inc.
Via
GlobeNewswire
Tickers
CING
CINGW
Cingulate Announces Successful Transfer of CTx-1301 (dexmethylphenidate) Proprietary PTR™ Manufacturing Processes to Societal CDMO
May 03, 2023
From
Cingulate Inc.
Via
GlobeNewswire
Tickers
CING
CINGW
SCTL
Cingulate to Participate in Benzinga All Live Access Event
April 14, 2023
From
Cingulate Inc.
Via
GlobeNewswire
Tickers
CING
CINGW
Cingulate Completes First Cohort of Phase 3 Adult Onset and Duration Trial of CTx-1301 (dexmethylphenidate) for ADHD
April 04, 2023
From
Cingulate Inc.
Via
GlobeNewswire
Tickers
CING
CINGW
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1